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Abstract 
The human gut symbiont Ruminococcus gnavus 
scavenges host‐derived N‐acetylneuraminic 
acid (Neu5Ac) from mucins, by converting it to 
2,7-anhydro-Neu5Ac. We previously showed 
that 2,7-anhydro-Neu5Ac is transported into R. 
gnavus ATCC 29149 before being converted 
back to Neu5Ac for further metabolic 
processing. However, the molecular 
mechanism leading to the conversion of 2,7-
anhydro-Neu5Ac to Neu5Ac remained elusive. 
Using 1D and 2D nuclear magnetic resonance 
(NMR), we elucidated the multistep enzymatic 
mechanism of the oxidoreductase (RgNanOx) 
that leads to the reversible conversion of 2,7-
anhydro-Neu5Ac to Neu5Ac through formation 
of a 4-keto-DANA intermediate and NAD+ 
regeneration. The crystal structure of RgNanOx 
in complex with the NAD+ cofactor showed a 
protein dimer with a Rossman fold. Guided by 
the RgNanOx structure, we identified catalytic 
residues by site-directed mutagenesis. 
Bioinformatics analyses revealed the presence 
of RgNanOx homologues across Gram negative 
and Gram positive bacterial species and co-
occurrence with sialic acid transporters. We 
showed by electrospray ionisation spray mass 
spectrometry (ESI-MS) that the Escherichia 
coli homologue YjhC displayed activity against 
2,7-anhydro-Neu5Ac and that E. coli could 
catabolise 2,7-anhydro-Neu5Ac. Differential 
scanning fluorimetry (DSF) analyses confirmed 
the binding of YjhC to the substrates 2,7-
anhydro-Neu5Ac and Neu5Ac, as well as to co-
factors NAD and NADH. Finally, using E. coli 
mutants and complementation growth assays, 
we demonstrated that 2,7-anhydro-Neu5Ac 
catabolism in E. coli was dependent on YjhC 
and on the predicted sialic acid transporter 
YjhB. These results revealed the molecular 
mechanisms of 2,7-anhydro-Neu5Ac 
catabolism across bacterial species and a novel 
sialic acid transport and catabolism pathway in 
E. coli.  
 
Introduction 
The sialic acids comprise a family of 9-carbon 
sugar acids found predominantly on cell surface 
glycans of humans and other animals (1). Sialic 
acids are subject to a remarkable number of 
modifications, generating more than 50 
structurally distinct molecules. Their terminal 
location makes them a preferential target for 
interaction with viruses and microorganisms at 
mucosa surfaces across the body (1). N-
acetylneuraminic acid (Neu5Ac), the most 
common form of sialic acid in humans, is a 
major epitope of mucin glycans which can 
serve as a metabolic substrate to the gut bacteria 
which have adapted to the mucosal 
environment (2). Most of our knowledge on 
sialic acid metabolism in bacteria comes from 
the study of Neu5Ac using the model organism 
E. coli (3). We previously reported that sialic 
acid metabolism is vital to the ability of 
Ruminococcus gnavus strains to utilise mucin 
as a nutrient source through the production of 
2,7-anhydro-Neu5Ac derivative (4,5). 
R. gnavus is a human gut symbiont which plays 
a major role in human health and disease.  R. 
gnavus is widely distributed amongst 
individuals being represented in the most 
common 57 species present in ≥90% of 
individuals (6). Colonisation by R. gnavus has 
been found in infants during the first days of 
life. R. gnavus is in the top 15 species showing 
abundance in both adult and infant gut-enriched 
genes, supporting R. gnavus adaptation to the 
intestinal habitat throughout life (6,7). Further, 
R. gnavus has been associated with an 
increasing number of intestinal or extra-
intestinal diseases including inflammatory 
bowel disease (8-16). 
The mucin-foraging strategy of R. gnavus is 
strain specific (5) and associated with the 
expression of an intramolecular trans-sialidase 
(IT-sialidase) that targets and cleaves off 
terminal α2-3-linked Neu5Ac from 
glycoproteins, releasing 2,7-anhydro-Neu5Ac 
instead of Neu5Ac (4,17,18). We unravelled the 
molecular pathway leading to the transport and 
metabolism of 2,7-anhydro-Neu5Ac in R. 
gnavus ATCC 29149 (19). The 2,7-anhydro-
Neu5Ac compound binds specifically to the 
substrate binding protein (RgSBP), which 
forms part of an ATP-binding cassette (ABC) 
sialic acid transporter in R. gnavus. Once inside 
the cell, 2,7-anhydro-Neu5Ac is converted into 
Neu5Ac via a novel enzymatic reaction 
catalysed by an oxidoreductase, RgNanOx. 
Following this conversion, Neu5Ac is then 
catabolised into N-acetylmannosamine 
(ManNAc) and pyruvate via the action of a 
Neu5Ac-specific aldolase (19). We confirmed 
the importance of this metabolic pathway in 
vivo by generating a R. gnavus nan cluster 
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deletion mutant that lost the ability to grow on 
sialylated substrates. We showed that in 
gnotobiotic mice colonised with R. gnavus 
wild-type and mutant strains, the fitness of the 
nan mutant was significantly impaired as 
compared to the wild-type strain with a reduced 
ability to colonise the mucus layer (19).  
The novel oxidoreductase identified in our 
work showed to catalyse the conversion 2,7-
anhydro-Neu5Ac to Neu5Ac in the presence of 
NAD+ in a reversible manner (19). Recently, 
the crystal structure of the RgNanOx 
homologue in Escherichia coli, YjhC, was 
solved in complex with NAD+ (20). However, 
the mechanism of action of these newly 
identified enzymes activity remained 
undefined. Here, using a combination of in 
silico, molecular, biochemical and structural 
approaches, we elucidated the molecular 
mechanism of RgNanOx and showed that 
homologous enzymes are present across both 
Gram positive and Gram negative bacteria, and 
associated with different classes of predicted 
transporters. We validated these data in vitro 
and further unravelled the 2,7-anhydro-Neu5Ac 
catabolism in E. coli. 
Results 
Characterisation of R. gnavus 
oxidoreductase (RgNanOx) reaction 
revealed a novel mechanism involving a 4-
keto-DANA intermediate 
RgNanOx (RUMGNA_02695) from R. gnavus 
ATCC 29149 catalyses the equilibration of 2,7-
anhydro-Neu5Ac and Neu5Ac (19). To gain 
insights into the mechanism of action of the 
enzyme, the conversion of 2,7-anhydro-
Neu5Ac to Neu5Ac was monitored by 1H NMR 
for 24 hours. Comparison of samples differing 
only in the solvent (light water (H2O) vs 
deuterated water (D2O)) at the same reaction 
time points showed the loss of specific 1H 
signals from protons attached at C3 and C5 in 
D2O indicating solvent exchange. The loss of 
these signals led to simplification in the 
splitting of the neighbouring protons signals 
(Supp. Fig. 1).  
Analysis of the reaction curve, obtained by 
monitoring the signals from the methyl protons 
of the acetamide group at C5, revealed the 
presence of a new (third) molecule (XY). This 
molecule is formed with a very fast kinetics, 
reaching its highest concentration at very early 
time points. It is consumed more slowly rate, 
suggesting that it is a reaction intermediate 
(Fig. 1A). The reaction mixture was analysed 
by 2D NMR during the interval at which the 
intermediate was at its highest concentration, 
using a 600 MHz spectrometer equipped with 
cryoprobe. The comparison of the 2D 1H,13C 
HSCQ spectra of the substrate (2,7-anhydro-
Neu5Ac), the product (Neu5Ac) and the 
reaction mixture at 30 min, allowed the 
identification of an additional set of cross peaks 
that did not belong to the substrate nor to the 
product, and were therefore assigned to the 
intermediate (Fig. 1B and C). Specifically, the 
presence of a heteronuclear cross peak at 2.73 
ppm/43.1 ppm (1H/13C) (Signal 2 in Fig. 1B), 
characteristic of a proton in α to a keto group, 
strongly suggested the intermediate to be a 
keto-sugar. Homonuclear 2D 1H,1H COSY and 
1H,1H TOCSY experiments showed 
connectivity of this proton to one and two other 
protons, respectively (Supp. Fig. 2). Signal 2, 
at 2.73 ppm, corresponds then to a proton 
neighbouring a carbonyl on one side and, at 
least, two other protons on the other side with 
chemical shifts in the 3-4 ppm region. Analysis 
of the 3-4 ppm spectral region, where standard 
sugar-ring C-H signals typically show, suggests 
that the intermediate chemical shifts are closer 
to Neu5Ac than to 2,7-anhydro-Neu5Ac (Supp. 
Fig. 3). Based on this information, we proposed 
that in this species the glycerol moiety is in the 
open form, meaning that the 2,7-anhydro bond 
is broken in the intermediate. The formation of 
such an oxidised intermediate (i.e. the keto-
sugar), as detected by NMR, is compatible with 
the regeneration of NAD+ previously observed 
(19). As the final result of the reaction is a 
reductive opening of the ring through the O7-
C2 bond, a preliminary oxidation must occur 
earlier on in the mechanism.  
Based on this analysis, we propose a multi-step 
mechanism for the reversible conversion of 2,7-
anhydro-Neu5Ac to Neu5Ac by RgNanOx 
(Fig. 2). In the first step, 2,7-anhydro-Neu5Ac 
is oxidised at the C4 keto by NAD+ cofactor. 
The proton at C3 is now  to the keto group, 
thus more acidic and can be abstracted in an 
anti-periplanar elimination reaction in which 
the 2,7-anhydro bond is also broken. The 
resulting compound, 4-keto-2-deoxy-2,3-
dehydro-N-acetylneuraminic acid (4-keto-
DANA), is consistent with 2D NMR, and the 
conjugation would be expected to stabilise the 
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intermediate (full NMR assignment of 4-keto-
DANA is given in Table S1). 4-keto-DANA 
exists as an equilibrium between two ring 
flipped forms, however the form with the 
equatorial glycerol and N-acetyl substituents 
would be expected to predominate. In this ring 
flipped form, a Michael addition of water to C2, 
hydrates the C2-C3 double bond with of a 
proton from the solvent added to C3. The 
addition reaction would be expected to follow 
the expected anti-periplanar geometry. This is 
consistent with the NMR observation that axial 
not equatorial on proton undergoes exchange 
(Supp. Fig. 1). The product of the addition (2) 
is a 4-keto-Neu5Ac, in which the proton at C5 
is now  to the keto and acidic. This acidic 
proton will exchange with solvent by the well-
known keto enol tautomerisation reaction, as 
seen the NMR data (Supp. Fig. 1). The 4-keto-
Neu5Ac (2) is finally reduced by NADH to 
yield the final Neu5Ac product and NAD+. The 
regeneration of NAD+ also explains why no net 
change in the ratio of NAD+ and NADH was 
observed in the enzymatic reaction (19).  
The crystal structure of RgNanOx in 
complex with NAD+ confirms structural 
homology with short chain 
dehydrogenase/reductases 
The crystal structure of the recombinant 
RgNanOx in complex with the NAD+ cofactor 
was solved at 2.58 Å and subsequently at 1.74 
Å using molecular replacement with an 
oxidoreductase from Agrobacterium 
radiobacter as a model (PDB 5UI9). The 
protein shows a Rossman fold typical of NAD 
binding protein of the Gfo/Idh/MocA class (21) 
characterised by a central β-sheet with helices 
on either side. RgNanOx forms a dimer in the 
asymmetric unit, and the NAD+ cofactor can be 
seen bound to the protein (Fig. 3A). Structural 
similarity search (22) identifies multiple 
oxidoreductase enzymes, all of which share the 
same Rossman fold and location of the 
nucleotide bind site Oxidoreductase proteins 
are typically have a catalytic triad of K (found 
in EKP motif), D and H (often found as DxxxH 
motif, in some enzymes Y replaces the H) and 
a fourth residue which is positively charged 
(21). RgNanOx has K93 and H178 which 
correspond to the K and H of the catalytic triad 
and K163 occupies the “fourth” position (23). 
However, RgNanOx has H175 which occupies 
the position typical for the D in the catalytic 
triad (23). The closest structural match (0.8 Å 
over 341 residues) is the recently solved crystal 
structure of YjhC oxidoreductase from 
Escherichia coli (Fig. 3B) (20) which also has 
HXXH motif. In the RgNanOx structure there 
is additional density adjacent to the 
nicotinamide ring that given the high resolution 
of the second structure we were able to 
unambiguously identify as citric acid from the 
crystallisation buffer. 
Using the high-resolution structure, we use a 
simple modelling approach to place a molecule 
of 2,3-didehydro-2-deoxy-N-acetylneuraminic 
acid (DANA), a transition state analog inhibitor 
of sialidases, in RgNanOx active site by 
overlapping the carboxylate acid of the DANA 
with each of the three carboxylate groups of 
citric acid. Next we manually positioned the 
sugar such that the H3 of atom ring pointed 
towards the C4’ of the nicotinamide as would 
be required for hydride transfer. These models 
were then minimised and inspected as to 
whether the H4 atom of DANA was still able to 
transfer to nicotinamide. Only one position 
(Fig. 3C) where the DANA carboxylate was 
placed on the 2-carboxylic acid of citric 
remained positioned for hydride transfer. The 
goal of modelling was not to generate a precise 
model of the substrate protein interactions but 
rather along with sequence comparisons, 
generate hypothesis for site-directed active site 
mutagenesis. The model indicated that H178, 
predicted to be a catalytic residue, is positioned 
to remove the proton from O4 during the 
oxidation step. H176 is plausibly positioned to 
undertake proton transfer with the O7 of the 
substrates glycerol that the mechanism requires. 
H175 interacts the negatively charged 
carboxylic acid in the model but could play a 
role in proton transfer at the substrate C3 atom. 
K93 binds to NAD+ and is part of the catalytic 
constellation is also within a plausible distance 
for proton transfer to C3. K163 binds to the 
NAD+ co-factor as well as interacting with the 
substrate carboxylate. The following mutants of 
RgNanOx were constructed K93A, K163A, 
H175A, H176A, H178A. The purified mutants 
lost enzymatic activity as demonstrated by 
electrospray ionisation spray mass 
spectrometry (ESI-MS) (Fig. 4A), supporting 
the hypothesis that they are catalytically 
important. K93A lost the ability to bind NAD+ 
as to some extent so did H176A (bound NAD+ 
in the presence of Neu5Ac and 2,7-anhydro-
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Neu5Ac).  The other mutants did appear able to 
retain substrate binding (Fig. 4B).  
Catabolism of 2,7-anhydro-Neu5Ac by 
Escherichia coli requires a RgNanOx 
homologue (YjhC) and a novel transporter  
Sequence similarity network (SSN) analysis of 
the R. gnavus Nan cluster (responsible for 2,7-
anhydro-Neu5Ac metabolism) identified the 
presence of RgNanOx homologues in a number 
of organisms (19). One such example was the 
model Gram negative human commensal 
Escherichia coli K-12, the organism in which 
the genes for Neu5Ac catabolism were first 
discovered (24,25). In E. coli, the homologue of 
RgNanOx is part of a two-gene operon, yjhBC, 
which is one of only three operons in E. coli 
regulated by the transcription factor NanR as 
previously reported (25) (Fig. 5A).  Here, we 
demonstrated that E. coli could grow on 2,7-
anhydro-Neu5Ac as a sole carbon source (Fig. 
5B), reaching growth yields similar to that 
obtained when E. coli was grown on Neu5Ac. 
Deletion of yjhC resulted in loss of growth on 
2,7-anhydro-Neu5Ac but not Neu5Ac (Fig. 
5C), which could be complemented in trans 
with yjhC (Fig. 5D), suggesting that the gene 
encodes an equivalent protein to RgNanOx. To 
test this hypothesis, the YjhC protein was 
recombinantly expressed, purified and its 
activity against 2,7-anhydro-Neu5Ac and 
Neu5Ac was analysed by ESI-MS. The purified 
enzyme was shown to be active against both 
substrates, reaching an equilibrium of 2:1 
Neu5Ac:2,7-anhydro-Neu5Ac, in line with that 
of RgNanOx (19) (Fig. 6A). DSF analyses 
confirmed the binding of YjhC to the substrates 
2,7-anhydro-Neu5Ac and Neu5Ac, as well as to 
co-factors NAD or NADH (Fig. 6B), as 
previously showed for RgNanOx (19). The 
knowledge of the biochemical and 
physiological function of YjhC is particularly 
insightful given that the 3D structure of this 
protein has also recently been solved (20).  
The first gene in the yjhBC operon, yjhB, 
encodes a major facilitator superfamily (MFS) 
transporter protein that shows homology (35% 
identify, 55% similarity) to NanT, the known 
Neu5Ac transporter in E. coli (24,26,27). 
Deletion of nanT leads to a complete loss of 
growth on Neu5Ac, suggesting that YjhB 
cannot transport this particular sialic acid (28) 
(Fig. 7A). Similar to the phenotype observed 
with the ΔyjhC strain, the ΔyjhB mutant was 
also unable to grow on 2,7-anhydro-Neu5Ac 
but could grow on Neu5Ac (Fig. 7B). The co-
expression of these two genes and the 
requirement of YjhB for growth on2,7-
anhydro-Neu5Ac suggest that YjhB is a novel 
MFS transporter for 2,7-anhydro-Neu5Ac and 
that these two gene together form an 
‘accessory’ operon to allow E. coli to scavenge 
a wider range of sialic acids that are available 
in the human gut. We propose to rename these 
genes nanXY, since the function of the final 
NanR-regulated operon has been elucidated 
through this work.  
 
Catabolism of 2,7-anhydro-Neu5Ac is 
widespread across the bacterial kingdom 
Having demonstrated that NanOx-like genes 
are functional in both Gram positive and Gram 
negative bacteria, functioning with different 
classes of transporters, we extended our 
analysis of the diversity of likely 2,7-anhydro-
Neu5Ac catabolic genes. Genes encoding 
proteins with high similarity to RgNanOx (ID% 
was ≥49%) were found in diverse micro-
organisms across the Firmicutes, 
Proteobacteria, and Actinobacterial phyla and 
were most often co-localised with other genes 
for sialic acid catabolism (Fig. 8). Interestingly, 
we showed co-occurrence of NanOx genes with 
known sialic acid transporters belonging to the 
major facilitator superfamily (MFS) 
transporters, sodium-solute symporter (SSS) 
transporter or ABC SAT transporters. To test 
the hypothesis that other bacteria can act as 
‘scavengers’ of 2,7-anhydro-Neu5Ac, we 
heterologously expressed and purified the 
NanOx protein from Haemophilus 
haemoglobinophilus and showed that the 
recombinant protein was active against 2,7-
anhydro-Neu5Ac (Fig. 6). The analysis also 
revealed two additional couplings of NanOx-
like genes to likely 2,7-anhydro-Neu5Ac 
transporters, namely to transporters of the SSS 
family, for example in Streptococcus 
pneumoniae TIGR4 and a transporter of the 
GPH family in Lactobacillus salivarius (Fig. 
8), which together with the phylogenetically 
broad occurrence of the NanOx-like genes, 
suggests that 2,7-anhydro-Neu5Ac use is not a 
new trait in bacteria but the result of a symbiotic 
evolution of bacteria in the mammalian 
gastrointestinal tract.  
 
Discussion 
Given the accessibility of sialic acids in mucus 
rich environments, their utilisation offers 
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pathogenic and commensal bacteria a 
competitive advantage to colonise and persist 
within the gut (2,19). The ability of R. gnavus 
strains to produce and metabolise 2,7-anhydro-
Neu5Ac, provide them with a nutritional 
advantage, by scavenging sialic acid from host 
mucus in a form that they have preferentially 
access to (4,17-19). We previously showed that 
the oxidoreductase RgNanOx plays a key role 
in the catabolism of 2,7-anhydro-Neu5Ac 
inside the cells by converting it into Neu5Ac, 
before being catabolised into GlcNAc-6-P 
following the canonical pathway by the 
successive action of NanA (Neu5Ac aldolase), 
NanK (ManNAc kinase) and NanE (ManNAc-
6-P epimerase). However, the molecular 
mechanism of RgNanOx enzymatic reaction 
remained unknown (19). Here we showed that 
RgNanOx acts through a multi-step mechanism 
involving a keto intermediate and cycling of 
NADH / NAD+. The creation of a keto 
intermediate in sugars is widespread biology, 
perhaps it is most well-known for the SDR 
enzyme UDP-glucose / galactose epimerase 
(29,30). In this enzyme, the oxidation and 
reduction of the sugar occur so as to invert the 
chirality at C4. In other enzymes, including 
RmlB of dTDP-L-rhamnose biosynthetic 
pathway (31) and the multi-step enzyme GDP-
mannose 3,5 epimerase (32), the creation of a 
keto group and the consequent acidification of 
the  proton(s) allows a range of chemical 
reactions. In RgNanOx by creating a keto 
group, the enzyme has acidified the C3 proton, 
this facilitates an elimination reaction and 
formation of a conjugated intermediate 4-keto-
DANA which we detected by NMR. The NAD+ 
co-factor is tightly bound, since in the overall 
reaction it is unchanged (acting as co-catalyst) 
there is no need to recycle it with an additional 
enzyme. Instead the NAD+ is reduced to NADH 
when it creates a keto group at C4 of the 
substrate in the first step and in the last step 
NAD+ is regenerated by reduction of the keto 
group.  
Previous work using spectrophotometric assays 
reported that E. coli YjhC showed a very small 
rate for Neu5Ac with an apparent KM of 68.8 
mM (20). Here we used ESI-MS to assess the 
activity of YjhC against 2,7-anhydro-Neu5Ac 
or Neu5Ac. This analysis supported the earlier 
findings that YjhC could act on Neu5Ac (20) 
but also revealed that enzyme was able to utilise 
2,7-anhydro-Neu5Ac as a substrate in the same 
manner as RgNanOx. Given the structural 
resemblance of RgNanOx to YjhC, it is likely 
that the E. coli oxidoreductase also uses the 
same mechanism of action for the reversible 
conversion of 2,7-anhydro-Neu5Ac to Neu5Ac.  
Further findings from our work support that the 
catabolism of 2,7-anhydro-Neu5Ac is not 
restricted to R. gnavus strains. E. coli can 
transport and catabolise the common sialic acid, 
Neu5Ac, as a sole source of carbon and 
nitrogen but also related sialic acids, N-
glycolylneuraminic acid (Neu5Gc) and 3-keto-
3-deoxy-D-glycero-D-galactonononic acid 
(KDN), which are transported via the sialic acid 
transporter NanT and catabolized using the 
sialic acid aldolase NanA (33). Here we showed 
that E. coli BW25113 strain was able to grow 
on 2,7-anhydro-Neu5Ac as a sole carbon source 
and that the two-gene NanR-regulated operon 
nanXY (yjhBC) encodes both the transporter 
and oxidoreductase enzyme required for E. coli 
to uptake and catabolise 2,7-anhydro-Neu5Ac. 
This also now completes the functional 
characterisation of all NanR-regulated genes 
(25) in E. coli, giving us a broader picture of the 
sialic acid molecules it likely encounters in its 
natural environment. This strategy contrasts 
with R. gnavus strains which can only grow on 
2,7-anhydro-Neu5Ac but not Neu5Ac (19) and 
is consistent with E. coli being able to integrate 
diverse sialic acids into its core catabolic 
pathway (33).  Beyond E. coli, our 
bioinformatics analyses revealed RgNanOx 
homologues across many bacterial species that 
also co-occurred with predicted sialic acid 
transporters. 
Bacteria have evolved multiple mechanisms to 
capture sialic acid from their environment 
(34,35). To date, 6 different classes of sialic 
acid transporters have been described (35). 
These include the NanT MFS transporters from 
E. coli and B. fragilis, which in E. coli has been 
demonstrated biochemically to be a H+-
coupled symporter (36). Secondary transporters 
implicated in sialic acid transport are from the 
SSS family present in pathogens such as C. 
difficile, S. typhimurium or P. mirabilis 
(28,37,38). High-affinity transport of sialic acid 
is mediated by substrate-binding protein-
dependent systems, including a tripartite ATP-
independent periplasmic (TRAP) transporter, 
SiaPQM, and a number of different ABC 
transporters (39-44). The sialic acid ABC 
transporters have been further classified into 3 
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types, SAT, SAT2 and SAT3 (34,35). To date 
all these transporters have been shown to 
transport Neu5Ac, with some being able to also 
transport the related sialic acids Neu5Gc and 
KDN (33,37). The exception is R. gnavus ABC 
SAT2 transporter, which we demonstrated was 
specific for 2,7-anhydro-Neu5Ac (19). Here we 
showed that in E. coli YjhC (NanY) is 
associated with a predicted sialic acid 
transporter, YjhB (NanX). Our genetic data 
suggest that YjhB could transport 2,7-anhydro-
Neu5Ac but not Neu5Ac, whether the 
previously characterised Neu5Ac transporter 
NanT was not able to transport 2,7-anhydro-
Neu5Ac. Based on its sequence, NanX (YjhB) 
is classified in the MFS class of sugar 
transporters and is a close homologue of NanT. 
Our bioinformatics provide striking evidence 
for two additional families of secondary 
transporters having evolved to recognise 2,7-
anhydro-Neu5Ac, namely those of the SSS and 
GPH families, bringing the total number of 
transporter families for 2,7-anhydro-Neu5Ac to 
four.  
It is of note that E. coli does not encode an IT-
sialidase releasing 2,7-anhydro-Neu5Ac, 
therefore the ability of this strain to use 2,7-
anhydro-Neu5Ac as a metabolic substrate in 
vivo would likely rely on cross-feeding in the 
mucosal environment. To date, only R. gnavus 
strains have been reported to produce 2,7-
anhydro-Neu5Ac from Neu5Ac terminally 
bound glycoconjugates in the gut (4,5,18). 
Resource sharing is an important ecological 
feature of microbial communities living in the 
gut (45). Some bacteria present in the mucus 
might not be primary degrader but might cross-
feed on mucin glycan degradation products 
released by other bacteria. This concept 
involves the ability of bacteria to benefit from 
substrate degradation products but also from 
fermentation products and plays a crucial role 
in microbial community shaping in the gut (46). 
Such cross-feeding activities have been 
reported in the gut mucosal environment for the 
utilisation of Neu5Ac. For example, 
Bacteroides thetaiotaomicron VPI-5482 
encodes a sialidase and can release free 
Neu5Ac but lacks the nan operon required to 
metabolise the liberated monosaccharide (47). 
On the other hand, most Clostridium difficile 
and Salmonella typhimurium subsp. enterica 
strains encode the nan operon but lack the 
sialidase (48) and benefit from sialidase-
producing organisms such as B. 
thetaiotaomicron to acquire this nutrient from 
the mucosal environment (49).  Our 
bioinformatics analyses suggest a similar 
diversity for 2,7-anhydro-Neu5Ac metabolism 
across bacterial species. For example, while R. 
gnavus possesses the full complement of genes 
to produce and utilise 2,7-anhydro-Neu5Ac, 
including the IT-sialidase (RgNanH), the 2,7-
anhydro-Neu5Ac SAT2 transporter and the 
oxido-reductase (RgNanOx) within the 
otherwise canonical Nan cluster, E. coli 
harbours a transporter with specificity for 2,7-
anhydro-Neu5Ac (NanX), the homologous 
NanOx (NanY) , but does not express an  IT-
sialidase. Streptococcus pneumoniae strains on 
the other hand, may express up to three 
sialidases (neuraminidases), NanA, NanB and 
NanC, of which the first two are part of a 
universally conserved nan gene cluster (42), 
while the third one is part of an additional locus 
present in some strains but not others (50). The 
conserved nan cluster is well studied in strain 
D39 (42,51), and is divided in three operons 
that include operon I (nanA monocistronic), 
operon II (the nanB locus), and operon III (the 
nanE locus carrying the catabolic genes) (51). 
Transcriptomic response of S. pneumoniae D39 
to Neu5Ac clearly demonstrated that NanR acts 
as a transcriptional activator of the nan operons 
I and III the presence of Neu5Ac, but not of 
operon II, for which regulation mechanisms 
remained unknown (51). Since NanB has been 
functionally characterised as an IT-sialidase in 
S. pneumoniae (52)  and that the nan operon II 
also contains a gene encoding an 
oxidoreductase and a SAT2 ABC transporter 
(as in the case of R. gnavus), our results 
strongly suggest that the nan operon II is 
dedicated to 2,7-anhydro-Neu5Ac utilisation. 
This is also in agreement with the reported 
growth assays of S. pneumoniae transporter 
mutants, showing that SAT3 was required for 
Neu5Ac transport but that growth on Neu5Ac 
was unaffected in SAT2 mutant (42), 
suggesting that SAT2 may be involved in 2,7-
anhydro-Neu5Ac, although this remains to be 
tested experimentally. The existence of 
multiple transporters with different specificities 
for sialic acid derivatives within the same 
species (e.g. E. coli NanT/YjhB) or restricted to 
2,7-anhydro-Neu5Ac (e.g. R. gnavus SAT2) 
points towards divergent evolution of a 
common ancestor. Together, these data 
demonstrate that 2,7-anhydro-Neu5Ac 
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catabolism is not exclusive to R. gnavus and 
may help shape microbial communities in the 
gut. From an ecological point of view, since R. 
gnavus is the only strain reported to produce 
2,7-anhydro-Neu5Ac in the gut, the strict 
specificity of its sialic acid transporter may give 
it a nutritional advantage while maintaining its 
keystone status in the mucus niche by providing 
an important nutrient to the microbial 
community. 
 
Experimental Procedures 
Materials and strains 
All chemicals were obtained from Sigma (St 
Louis, MO, USA) unless otherwise stated. The 
Auto-induction media (AIM) ‘Terrific Broth 
Base with Trace Elements' autoinduction media 
was purchased from ForMedium (Dundee, 
UK). 2,7-anhydro-Neu5Ac was produced as 
reported in Bell et al. (19). The E. coli nanT, 
yjhB (JW5768), and yjhC (JW5769) mutants 
all come from the KEIO collection (53) and are 
derivatives of BW25113, which we used as WT 
strain. The nanT strain, which we have 
previously characterised (28,36) carries an un-
marked deletion, while the yjhB andyjhC 
mutants are un-modified and retain the original 
Kan marker. 
 
Bacterial growth assays 
Growth curves of E. coli BW25113 and 
sialometabolism mutants (ΔnanT, ΔyjhC and 
ΔyjhB) before or after complementation were 
carried out in M9 medium (without glucose) 
supplemented with 11.1 mM Neu5Ac, 2,7-
anhydro-Neu5Ac or glucose using 200 µl 
cultures in 96-well microtiter plates. The 
OD595nm was measured every 30 or 60 min for 
16 h in a FLUOstar OPTIMA (BMG 
LABTECH).  
 
Complementation of E. coli yjhC  
Plasmid pES156 is a derivative of the low-copy 
plasmid pWKS30 (Wang and Kushner, 1991) 
carrying E. coli yjhBC under the control of the 
lac promoter. To make pES156 a PCR product 
for the yjhBC genes was amplified with primers 
E549 and E550 (Table S2) cut with Eco31I (the 
primers carried sites for this type IIS enzyme 
that were designed to produce Acc65I- and 
BamHI-compatible ends) and ligated in to 
pWKS30. The constructs were verified by 
sequencing. The resulting plasmid was 
transformed into chemically competent yjhC 
cells using heat shock. For bacterial growth 
curves 1mM IPTG was added to the growth 
medium for induction of the yjhBC proteins. 
 
Cloning, site-directed mutagenesis, 
heterologous expression and protein 
purification  
RgNanOx was heterologously expressed and 
purified as previously described (19). Mutants 
of RgNanOx were generated using the 
NZYMutagenesis kit (NZYTech) using the 
primers listed in Table S2 following the 
manufacturer’s instructions, expressed and 
purified as previously described for the wild-
type enzyme (19). Fractions collected following 
gel filtration were analysed using NuPAGE 
Novex 4-12 % Bis-Tris gels (Life 
Technologies, UK). Fractions were pooled and 
concentrated using a 10-kDa MWCO Vivaspin 
column (Vivaspin, Germany). Protein 
concentration was determined by NanoDrop 
(Thermo Scientific, USA) using extinction 
coefficients calculated by Protparam (ExPASy-
Artimo, 2012) from the peptide sequence.  
The oxidoreductase genes encoding YjhC from 
E. coli BW25113 and the homologue in H. 
haemoglobinophilus CCUG 3714 
(B0186_5960; strain purchased from DSMZ, 
ref DSM21241) were amplified from genomic 
DNA with HerculaseIIFusion (Agilent) using 
primer pairs E521 and E522, and ES525 and 
ES526, respectively (Table S2).The PCR 
products, each flanked by sites for Type IIS 
enzyme Eco31I (BsaI) designed to produce 
NcoI and XhoI compatible ends, were digested 
with Eco31I and ligated in pET28a digested 
with NcoI and XhoI. The resulting constructs 
were confirmed by sequencing.  
For purification of these recombinant proteins, 
the corresponding expression plasmids were 
transformed into BL21(DE3) pLysS, and single 
colonies were grown overnight in 10 ml LB 
with Cm15 Kan25. These starters were used to 
inoculate 1 L of Terrific Broth (TB 47.6 g/L, 
glycerol 0.5% v/v) with antibiotics. Cultures 
were grown in baffled flasks at 37 °C and 200 
rpm until 0.7 OD650 before being quickly chilled 
on ice-water for about 20 min and finally 
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induced overnight with 0.2 mM IPTG at 18 °C 
and 220 rpm. After harvest, pellets were 
resuspended in equilibration buffer (50 mM 
KPi, 200 mM NaCl, 20% glycerol, 40 mM 
imidazole, pH 7.8) and disrupted with 
sonication. The clarified lysate was run through 
an IMAC column to elute the C-terminally 
His6-tagged proteins, which eluted in sharp 
peaks with a single 500 mM imidazole step. 
These were further purified by SEC with 
elution in 50 mM KPi, 200 mM NaCl, pH 7.8, 
dialysed against assay buffer (20 mM Tris, 150 
mM NaCl, 2 mM TCEP, pH 7.5), and finally 
concentrated to 0.5-1 mM for storage at 4 °C. 
Purity was assessed on SDS PAGE as above. 
 
ESI-MS analysis of the oxidoreductase 
reaction  
To assay for oxidoreductase activity, the 
purified recombinant proteins were incubated 
in 100 μl reactions at 37 °C overnight with 1 
mg/ml 2,7-anhydro-Neu5Ac or Neu5Ac in 20 
mM sodium phosphate buffer pH 7.5, in the 
presence 500 μM NADH. The conversion of 
2,7-anhydro-Neu5Ac to Neu5Ac or Neu5Ac to 
2,7-anhydro-Neu5Ac was monitored by ESI-
MS. Briefly, 100 µl acetonitrile was added to 
each reaction, vortexed and centrifuged to 
remove particles. The resulting supernatants 
were loaded onto an AmaZon Speed ETD 
(Bruker) mass spectrometer and analysed by 
direct injection in negative mode. 
 
NMR analyses of the oxidoreductase 
reaction 
All 1D NMR experiments were performed 
using a Bruker Advance I 500MHz 
spectrometer with a 5 mm PATXI 1H/D-
13C/15N Z-GRD probe at 293 K. To follow the 
kinetics of the reaction and assess the position 
of deuteration, two samples containing 2 mM 
2,7-anhydro-Neu5Ac, 100 μM NADH and 60 
μM RgNanOx were used, one in deuterated 
PBS buffer (PBS/D2O) and one in standard PBS 
buffer (PBS/H2O, containing 10% D2O for 
locking purposes). The reaction was followed 
by acquiring 1D NMR experiments at 15 min 
intervals, over 24 h. The standard zg pulse 
sequence was used for the D2O sample, while 
excitation sculpting was used to remove the 
strong solvent signals for the H2O sample 
(pulse sequence: zgesgp). 1 mM DSS-d6 was 
added to each sample as an internal reference 
and the signal calibrated to 0 ppm. All 2D-
NMR experiments were performed using an 
Avance NEO 600 MHz NMR spectrometer 
equipped with He-cooled TCI cryoprobe. 
Typically, a spectral width of 12 ppm was used 
for 1H and 165 ppm for 13C, acquiring 8 scans 
per experiment with a TD of 2K data points in 
the direct dimension and 128 experiments in the 
indirect dimension. To characterise the reaction 
intermediate, a sample containing 3 mM 2,7-
anhydro-Neu5Ac, 100 µM NADH, 15 µM 
RgNanOx and 1 mM DSS-d6 in PBS/D2O was 
prepared and analysed at 293 K. A full set of 
2D-NMR experiments, including HSQC 
(hsqcetgpsi), COSY (cosygpqf), TOCSY 
(mlevph) and TOCSY-HSQC (hsqcdietgpsi), 
was acquired in order to fully assign 1H and 13C 
signals of the intermediate. 
 
Differential scanning fluorimetry (DSF) 
The Applied Biosystems StepOnePlus Real-
Time PCR system (Life Technologies Ltd) was 
used to record the thermal stability of the 
purified proteins with and without substrates or 
cofactors. Reactions were performed in 20 mM 
sodium phosphate pH7.5 and consisted of 5 μM 
protein, 5x SYPRO Orange (prepared as a 40x 
stock), 10 mM substrate (2,7-anhydro-Neu5Ac 
or Neu5Ac), 1 mM cofactor (NAD or NADH) 
in a 20 μL final reaction volume. Samples were 
heated from 10 °C to a 99 °C in 0.5 °C 
increments, taking fluorescent readings at each 
time point. Triplicate measurements were 
performed for each sample. Negative controls 
were included for each component of the 
experiment individually as well as a dye only 
control well. The melting point (Tm) of each 
sample in °C was obtained from the lowest 
point of the first derivative plot. 
 
Crystallization, data collection and structure 
determination of RgNanOX  
Sitting drop vapour diffusion crystallisation 
experiments of RgNanOx were set up at a 
concentration of 20 mg/ml. The structure was 
acquired from a crystal grown in the JCSG Plus 
screen (100 mM sodium citrate pH 5.5, 20% 
PEG 3000). The diffraction experiment was 
performed on the I04 beamline at Diamond 
Light Source Ltd at 100K using a wavelength 
of 0.9795 Å. The data were processed with Xia2 
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pipeline. The structure was phased using online 
MrBump Sculptor pipeline (54) with PDB 
5UI9. Refinement was carried out using Phenix 
AutoBuild (55), Refmac (56), and PDB redo 
(57). Coot (58) was used for manual model 
building and Molprobity (59) for structure 
validation. It has not yet been possible to obtain 
well diffracting crystals of any substrate 
analogue complexed the protein. For 
modelling, after manual positioning in COOT 
the structure was idealised using REFMAC5 
(56). 
 
Bioinformatics 
To search and compare protein sequences for 
RgNanOx, the basic local alignment search tool 
(BLAST) program and BLASTp (60) were 
used. The DALI server (61) was used for 
protein structure comparison. Amino acid 
sequences and atomic structures of homologues 
were sourced from the NCBI/UniProt and 
Protein Data Bank (PDB) databases, 
respectively. BLAST searches were initiated 
with RgNanOx/YjhC as queries followed by 
manual annotation of the ORFs going outwards. 
To map complete sialometabolic pathways 
within individual micro-organisms, BLAST 
searches were performed against all known 
Neu5Ac transporters (35) as well as for the 
Neu5Ac aldolase NanA and N-
acetylmannosamine-6-phosphate epimerase 
NanE (using queries of different organismal 
origin). This was carried out to include 
annotation of genes for RgNanOx homologues 
residing outside the cluster, or where multiple 
sialometabolic clusters were present. 
 
Data availability 
The atomic coordinates have been deposited in 
the Protein Data Bank under accession codes 
6Z3B (2.58 Å resolution structure of 
RgNanOx), and 6Z3C (1.74 Å resolution 
structure of RgNanOx). The authors declare 
that all other data supporting the findings of this 
study are available within the article and its 
supplementary information files. 
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Figure 1. NMR characterisation of the RgNanOx-catalysed enzymatic reaction. A) 1H 1D-NMR 
analysis of the conversion of 2,7-anhydro-Neu5Ac to Neu5Ac via the XY intermediate; evolution of 
the concentrations of substrate, product, and intermediate of the reaction, [X](mM), by integration of 
the acetyl methyl groups for Neu5Ac (blue), 2,7-anhydro-Neu5Ac (orange) or XY intermediate 
(grey). B,C) Superposition of the 1H,13C HSQC reference spectra of  Neu5Ac (blue) and 2,7-anhydro-
Neu5Ac (orange), and 1H,13C HSQC reaction mixture at 30 min (where the XY peak is observed to 
peak, grey). Proton-carbon peaks not corresponding to Neu5Ac nor to 2,7-anhydro-Neu5Ac are 
numbered from 1 to 6 and circled in green. 
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Figure 2. Proposed mechanism for the reversible conversion of Neu5Ac to 2,7-anhydro-Neu5Ac by 
RgNanOx. The reaction is shown in the favourable direction converting 2,7-anhydro-Neu5Ac (1) to 
Neu5Ac (6). The order of events taking compound 2 to compound 4 including the opening of the 2,7 
secondary ring and the primary ring flip has yet to be determined. The red arrows indicate the keto 
enol tautomerization of compound 5 that allows for the C5 hydrogen exchange. 
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Figure 3. Crystal structure of RgNanOx. A) Dimeric structure of RgNanOx shown in cartoon format 
with the NAD cofactor bound (spheres). B) Structure of putative active site of RgNanOx, protein 
backbone is shown in cartoon with residues NAD and citric acid shown in sticks. C) Crystal structure 
of RgNanOx with key residues marked and DANA modelled into the active site, The red line marks 
the trajectory of hydride transfer. 
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Fig. 4: Analysis of RgNanOx mutants. A) ESI-Ms analysis of the enzymatic reaction between RgNanOx 
mutants and 2,7-anhydro-Neu5Ac (290; left) or Neu5Ac (308; left). B) DSF analysis of RgNanOx 
mutants binding to NAD/H cofactor and sialic acid substrates. The ΔTm is shown compared to the Tm 
of the protein alone. 
 
Figure 5. Structure of the sialometabolic nan regulon of E. coli K12 strains and the role of YjhC in 
sialometabolism by E. coli BW25113. A) Structure of the complete sialometabolic regulon of E. coli 
K12 strains. The repressor NanR controls expression of only these three loci in E. coli (25), with 
nanOp indicating the position of NanR-regulated promoters. The first locus is the core nanATEKyhcH 
operon for Neu5Ac uptake and dissimilation into the cytoplasm (62). The two “accessory” loci 
contain the nanCMS operon, for Neu5Ac uptake through the outer membrane, sialic acid mutarotation 
and processing of O-acetyled sialic acids in periplasm (63-65), and the nanXY (yjhBC) operon here 
characterised as being required for 2,7-anhydro-Neu5Ac uptake and utilisation. B to D) Growth of E. 
coli on different carbon sources. All strains were grown on 2,7-anhydro-Neu5Ac (red), Neu5Ac 
(blue), glucose (orange) or M9 media alone (black) in 200 µl microtitre plates. ΔOD595 for triplicate 
experiments is shown B) BW25113 C)   Δ yjhC, D) complemented yjhC. Error bars display standard 
error of 3 biological repeats 
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Fig. 6: Characterisation of EcNanOx and HhNanOx. A) ESI-MS analysis of the enzymatic reaction of 
RgNanOx, EcNanOx and HhNanOx with 2,7-anhydro-Neu5Ac (left) or Neu5Ac (right). B) DSF 
analysis of RgNanOx and EcNanOx, the ΔTm is shown compared to the Tm of the protein alone. 
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Figure 7. Growth of sialometabolism E. coli BW25113 transporter mutants. Both mutants were 
grown on 2,7-anhydro-Neu5Ac (red), Neu5Ac (blue), glucose (orange) or M9 media alone (black) in 
200 µl microtitre plates. ΔOD595 for triplicate experiments is shown A) Δ nanT B) Δ yjhB. Error bars 
display standard error of 3 biological repeats 
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Fig. 8: Diversity of 2,7-anhydro-Neu5Ac catabolic clusters among sialic acid-utilising bacteria.  Gene 
functions were inferred from BLAST searches followed by gene linkage and cluster analysis. 
Orthologous genes are identified with individual patterns. The genes encoding 2,7-anhydro-Neu5Ac 
transporters, 2,7-anhydro-Neu5Ac oxidoreductases, and IT-sialidases are distinguished by colour for 
emphasis. Nomenclature: nanA: Neu5Ac lyase; nanK:  N-acetylmannosamine kinase; nanE: N-
acetylmannosamine-6-phosphate epimerase; nanC: Neu5Ac outer membrane channel; nanM: Neu5Ac 
mutarotase; nanS: N-acetyl-9-O-acetylneuraminate esterase; nagB: glucosamine-6-phosphate 
deaminase; “GNAT”: GCN5-related N-acetyltransferase; “Reg”: regulator (please note that GNAT 
family proteins and regulator proteins, while recurrent within clusters, may belong to different clades 
thus function differently in each organism); SAT2: 2,7-anhydro-Neu5Ac transporter of the ABC 
superfamily; siaPQM: Neu5Ac transporter of the TRAP family; satABCD: Neu5Ac transporter of the 
ABC superfamily (SAT); nanUVW (SAT3): Neu5Ac transporter of the ABC superfamily (also named 
satABC); nanT: Neu5Ac transporter of the MFS superfamily; siaT: Neu5Ac transporter of the SSS 
family; nanX (yjhB): 2,7-anhydro-Neu5Ac transporter (nanT-like) of the MFS superfamily ABC: ATP-
binding cassette; MFS: major facilitator superfamily; SSS: sodium-solute symporter family; GPH: 
Glycoside-pentoside-hexuronide:cation symporter family. SBP: solute binding protein; TMD: 
transmembrane domain; NBD: nucleotide binding domain. Note that the classification of ABC sialic 
acid transporters follows Almagro-Moreno & Boyd (34). 
*: TIGR4 possesses both the conserved sialic acid “supercluster” as in strain D39, and an additional, 
candidate 2,7-anhydro-Neu5Ac cluster bearing the siaT-like transporter gene. In TIGR4, the conserved 
supercluster bears minor difference in the form of pseudogenes and insertions (66). 
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